Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2013

Conditions
Chronic Ischaemic Heart Failure
Interventions
DRUG

Granulocyte-colony stimulating factor

5 days subcutaneous injection

PROCEDURE

Percutaneous intracoronary injection

Bone marrow derived stem/progenitor cells or placebo infusion is delivered through an over-the-wire balloon catheter into the target coronary vessels using a stop-flow technique.

PROCEDURE

Percutaneous intramyocardial injection

Direct intramyocardial injections of bone marrow derived stem/progenitor cells or placebo will be delivered using the electromechanical NOGA mapping and injection system

Trial Locations (1)

E2 9JX

London Chest Hospital, Barts and the London NHS Trust, London

All Listed Sponsors
lead

Barts & The London NHS Trust

OTHER

NCT00747708 - Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure | Biotech Hunter | Biotech Hunter